Baseline [ 18 F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy.
Carla OliveiraFrancisco P M OliveiraCláudia S ConstantinoCeleste AlvesMaria José BritoFatima CardosoDurval C CostaPublished in: European journal of nuclear medicine and molecular imaging (2024)
F]FDG PET-based features from primary BC and ALN are not associated with response to NAC, except in HER2-negative tumors. As compared with pathological features, no breast tumor-extracted PET or MRI-based feature improved response prediction.